Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
The Possible Immunological Mechanisms of Pathology in Mice with Congenitally Acquired Influenza Infection.

Russian journal of immunology : RJI : official journal of Russian Society of Immunology

Kobets NV, Deeva AV, Mirchink EP, Pronin AP, Chernyakhovskaya IY, Zuev VA.
PMID: 12687066
Russ J Immunol. 1997 Jul;2(2):121-128.

The fact that congenitally acquired viral infection often strongly influences specific and non-specific immunoreactivity is well documented. Viral infection of pregnant female may lead to serious of pathological consequences for the offspring, namely, to mortality, developmental disorders and in...

Cite
Kobets NV, Deeva AV, Mirchink EP, et al. The Possible Immunological Mechanisms of Pathology in Mice with Congenitally Acquired Influenza Infection. Russ J Immunol. 1997;2(2):121-128
Kobets, N. V., Deeva, A. V., Mirchink, E. P., Pronin, A. P., Chernyakhovskaya, I. Y., & Zuev, V. A. (1997). The Possible Immunological Mechanisms of Pathology in Mice with Congenitally Acquired Influenza Infection. Russian journal of immunology : RJI : official journal of Russian Society of Immunology, 2(2), 121-128.
Kobets, N. V., et al. "The Possible Immunological Mechanisms of Pathology in Mice with Congenitally Acquired Influenza Infection." Russian journal of immunology : RJI : official journal of Russian Society of Immunology vol. 2,2 (1997): 121-128.
Kobets NV, Deeva AV, Mirchink EP, Pronin AP, Chernyakhovskaya IY, Zuev VA. The Possible Immunological Mechanisms of Pathology in Mice with Congenitally Acquired Influenza Infection. Russ J Immunol. 1997 Jul;2(2):121-128. PMID: 12687066.
Copy Download .nbib Format: NLM
Aminoalkylamides of Eremomycin Exhibit an Improved Antibacterial Activity.

Pharmaceuticals (Basel, Switzerland)

Moiseenko EI, Erdei R, Grammatikova NE, Mirchink EP, Isakova EB, Pereverzeva ER, Batta G, Shchekotikhin AE.
PMID: 33921612
Pharmaceuticals (Basel). 2021 Apr 19;14(4). doi: 10.3390/ph14040379.

After decades, the glycopeptide vancomycin is still the preferred antibiotic against resistant strains of Gram-positive bacteria. Although its clinical use is strictly regulated, the gradual spread of vancomycin-resistant bacteria, such as glycopeptide-resistant and glycopeptide-intermediate

Cite
Moiseenko EI, Erdei R, Grammatikova NE, et al. Aminoalkylamides of Eremomycin Exhibit an Improved Antibacterial Activity. Pharmaceuticals (Basel). 2021;14(4)doi: 10.3390/ph14040379.
Moiseenko, E. I., Erdei, R., Grammatikova, N. E., Mirchink, E. P., Isakova, E. B., Pereverzeva, E. R., Batta, G., & Shchekotikhin, A. E. (2021). Aminoalkylamides of Eremomycin Exhibit an Improved Antibacterial Activity. Pharmaceuticals (Basel, Switzerland), 14(4), . https://doi.org/10.3390/ph14040379
Moiseenko, Elena I, et al. "Aminoalkylamides of Eremomycin Exhibit an Improved Antibacterial Activity." Pharmaceuticals (Basel, Switzerland) vol. 14,4 (2021). doi: https://doi.org/10.3390/ph14040379
Moiseenko EI, Erdei R, Grammatikova NE, Mirchink EP, Isakova EB, Pereverzeva ER, Batta G, Shchekotikhin AE. Aminoalkylamides of Eremomycin Exhibit an Improved Antibacterial Activity. Pharmaceuticals (Basel). 2021 Apr 19;14(4). doi: 10.3390/ph14040379. PMID: 33921612; PMCID: PMC8072890.
Copy Download .nbib Format: NLM
Showing 1 to 2 of 2 entries